Literature DB >> 9581808

Inhibition of p130cas tyrosine phosphorylation by calyculin A.

W Qiu1, R R Cobb, W Scholz.   

Abstract

P130cas is a dominant tyrosine phosphorylated protein in v-src-and v-crk-transformed cells. Tyrosine phosphorylation also occurs in response to integrin-mediated cell adhesion. P130cas has a unique structure with multiple SH2 and SH3 binding sites, which makes it a candidate docking protein that might be involved in several signal transduction pathways. Little is known about how p130cas itself is regulated. In this report we present evidence that tyrosine phosphorylated p130cas was rapidly dephosphorylated in several lymphatic cell lines after treatment with calyculin A, a serine/threonine phosphatase inhibitor. A similar result was obtained with okadaic acid, but higher concentrations and longer incubation times were required. Constitutive phosphorylation as well as receptor-cross linking-induced p130cas phosphorylation was inhibited. Furthermore, the p130cas-Crk association was disrupted by treatment of cells with calyculin A. However, the p130cas-Lyn association was not affected. These results suggest that calyculin A specifically affects SH2 domain-mediated protein-protein interactions and that Lyn does not bind to a susceptible SH2 domain. Furthermore, the data presented is consistent with the existence of a calyculin A-sensitive phosphatase or tyrosine kinase that may be a critical regulator of p130cas tyrosine phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581808     DOI: 10.1002/jlb.63.5.631

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  CIN85 modulates the down-regulation of Fc gammaRIIa expression and function by c-Cbl in a PKC-dependent manner in human neutrophils.

Authors:  Louis Marois; Myriam Vaillancourt; Guillaume Paré; Valérie Gagné; Maria J G Fernandes; Emmanuelle Rollet-Labelle; Paul H Naccache
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

2.  Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration.

Authors:  Chung-Huang Chen; Yen-Chun Ho; Hua-Hui Ho; Il-Chi Chang; Kathrin H Kirsch; Yung-Jen Chuang; Matthew D Layne; Shaw-Fang Yet
Journal:  Cardiovasc Res       Date:  2013-08-23       Impact factor: 10.787

3.  Identification of afzelin potential targets in inhibiting triple-negative breast cancer cell migration using reverse docking.

Authors:  Eva Rachmi; Basuki Bambang Purnomo; Agustina Tri Endharti; Loeki Enggar Fitri
Journal:  Porto Biomed J       Date:  2020-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.